MassMutual Private Wealth & Trust FSB trimmed its position in Elevance Health, Inc. (NYSE:ELV – Free Report) by 53.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 694 shares of the company’s stock after selling 782 shares during the period. MassMutual Private Wealth & Trust FSB’s holdings in Elevance Health were worth $256,000 at the end of the most recent quarter.
Other institutional investors and hedge funds also recently modified their holdings of the company. State Street Corp lifted its stake in Elevance Health by 1.2% in the 3rd quarter. State Street Corp now owns 10,687,998 shares of the company’s stock valued at $5,557,759,000 after acquiring an additional 129,709 shares in the last quarter. Geode Capital Management LLC grew its stake in shares of Elevance Health by 1.8% during the 3rd quarter. Geode Capital Management LLC now owns 4,848,020 shares of the company’s stock worth $2,511,814,000 after acquiring an additional 85,770 shares in the last quarter. Sanders Capital LLC raised its holdings in shares of Elevance Health by 1.0% in the third quarter. Sanders Capital LLC now owns 4,609,258 shares of the company’s stock valued at $2,396,814,000 after purchasing an additional 44,805 shares during the last quarter. Wellington Management Group LLP lifted its position in shares of Elevance Health by 6.9% in the third quarter. Wellington Management Group LLP now owns 4,461,585 shares of the company’s stock worth $2,320,024,000 after purchasing an additional 286,905 shares in the last quarter. Finally, Ameriprise Financial Inc. boosted its holdings in Elevance Health by 5.3% during the second quarter. Ameriprise Financial Inc. now owns 3,791,793 shares of the company’s stock worth $2,054,641,000 after purchasing an additional 190,118 shares during the last quarter. 89.24% of the stock is owned by institutional investors and hedge funds.
Analyst Ratings Changes
ELV has been the topic of several recent research reports. Morgan Stanley lowered their price target on shares of Elevance Health from $643.00 to $551.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 23rd. StockNews.com raised Elevance Health from a “hold” rating to a “buy” rating in a research report on Friday, January 17th. Stephens downgraded Elevance Health from an “overweight” rating to an “equal weight” rating and decreased their price target for the company from $520.00 to $440.00 in a research note on Wednesday. UBS Group dropped their price objective on Elevance Health from $605.00 to $555.00 and set a “buy” rating on the stock in a research note on Friday, October 18th. Finally, Wells Fargo & Company decreased their target price on shares of Elevance Health from $593.00 to $495.00 and set an “overweight” rating for the company in a research note on Monday, November 4th. Three equities research analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, Elevance Health currently has an average rating of “Moderate Buy” and a consensus target price of $524.87.
Elevance Health Trading Up 0.3 %
Shares of NYSE:ELV opened at $390.21 on Thursday. Elevance Health, Inc. has a 12-month low of $362.21 and a 12-month high of $567.26. The business has a 50 day moving average of $386.73 and a 200-day moving average of $464.16. The company has a quick ratio of 1.50, a current ratio of 1.50 and a debt-to-equity ratio of 0.56. The stock has a market cap of $90.50 billion, a PE ratio of 14.23, a P/E/G ratio of 1.09 and a beta of 0.84.
Elevance Health Company Profile
Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.
Further Reading
- Five stocks we like better than Elevance Health
- What Are Some of the Best Large-Cap Stocks to Buy?
- Oracle Announces Game-Changing News for the AI Industry
- What Are Growth Stocks and Investing in Them
- Netflix Adds 19 Million Subscribers, Growth Is Far From Over
- EV Stocks and How to Profit from Them
- Tempus AI: A Game-Changer in AI-Powered Healthcare
Receive News & Ratings for Elevance Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Elevance Health and related companies with MarketBeat.com's FREE daily email newsletter.